Half-year report · Q2
9221.TEDINET S100UR2A
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥8.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥444m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥491m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥663m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥687m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥666m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥703m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥445m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥263m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥483m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥445m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥483m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥11.5bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥11.3bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥11.3bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.2bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥6.3bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.3bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.0bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥670m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥982m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥635m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥112m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥202m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥642m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥37.82 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.41 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.12 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥718m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥542m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥176m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥6m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥215m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥215m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥9m |
| jpcrp040300-q2r_E37560-000Biomaterial Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E37560-000Biomaterial Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| jpcrp040300-q2r_E37560-000Biomaterial Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥36m |
| jpcrp040300-q2r_E37560-000Biomaterial Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥470m |
| jpcrp040300-q2r_E37560-000Resource Circulation Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥713m |
| jpcrp040300-q2r_E37560-000Resource Circulation Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥709m |
| jpcrp040300-q2r_E37560-000Resource Circulation Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥3m |
| jpcrp040300-q2r_E37560-000Resource Circulation Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥10m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.0bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥39m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥460m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥215m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥453m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥572m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥458m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥114m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥24m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥142m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥142m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | ¥649,000 |
| jpcrp040300-q2r_E37560-000Biomaterial Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E37560-000Biomaterial Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E37560-000Biomaterial Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥24m |
| jpcrp040300-q2r_E37560-000Biomaterial Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥433m |
| jpcrp040300-q2r_E37560-000Resource Circulation Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥726m |
| jpcrp040300-q2r_E37560-000Resource Circulation Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥723m |
| jpcrp040300-q2r_E37560-000Resource Circulation Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥4m |
| jpcrp040300-q2r_E37560-000Resource Circulation Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥34m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥3.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥3.7bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥28m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥467m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥142m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥491m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 509
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 113569000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 141559000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -141559000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E37560-000BiomaterialBusinessReportableSegmentMember | 3051568000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E37560-000ResourceCirculationBusinessReportableSegmentMember | 726309000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 3777877000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 571686000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 4349564000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -141559000 | JPY |
| Net sales | Prior1YTDDuration | 4208005000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E37560-000BiomaterialBusinessReportableSegmentMember | 432503000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E37560-000ResourceCirculationBusinessReportableSegmentMember | 34485000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 466989000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 23739000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 490728000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 649000 | JPY |
| Operating income | Prior1YTDDuration | 491377000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E37560-000BiomaterialBusinessReportableSegmentMember | 3226946000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E37560-000ResourceCirculationBusinessReportableSegmentMember | 709471000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 3936418000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 542441000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 4478859000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 4478859000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E37560-000BiomaterialBusinessReportableSegmentMember | 36008000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E37560-000ResourceCirculationBusinessReportableSegmentMember | 3100000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 39108000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 175857000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 214966000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -214966000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E37560-000BiomaterialBusinessReportableSegmentMember | 3262954000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E37560-000ResourceCirculationBusinessReportableSegmentMember | 712572000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 3975526000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 718299000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 4693826000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -214966000 | JPY |
| Net sales | CurrentYTDDuration | 4478859000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E37560-000BiomaterialBusinessReportableSegmentMember | 469881000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E37560-000ResourceCirculationBusinessReportableSegmentMember | -10170000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 459710000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -6379000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 453330000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -9172000 | JPY |
| Operating income | CurrentYTDDuration | 444158000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)東海財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-11-13 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |